FRANKFORT, Ky. (Legal Newsline) – Kentucky Attorney General Jack Conway announced a $35 million multi-state settlement with Pfizer Inc. on Wednesday to resolve allegations that one of its subsidiaries unlawfully promoted a kidney transplant drug.
Wyeth Pharmaceuticals Inc. allegedly misrepresented the uses and benefits of Rapamune, an immunosuppressive drug currently approved by the Food and Drug Administration for use after kidney transplant surgery to counteract organ rejection. Wyeth allegedly promoted the unapproved use of Rapamune following organ transplants other than kidney transplants, the use of Rapamune in unapproved drug combinations and the unapproved protocol of converting patients to Rapamune after first receiving a different drug.
